Dynavax Co-founder Takes Long View on Vaccine Development
Xconomy
DECEMBER 4, 2017
For Dennis Carson, however, the FDA announcement represented the culmination of a scientific odyssey that took 21 years. To him, vaccines represent a paradigm in preventive health—even though vaccines take longer to develop and typically don’t bring. In the days following the company’s Nov. a share to $18.45
Let's personalize your content